logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 [see all tables in this series...]

Part (i) Percentage distribution of new outpatient clients by age at first use for each primary drug

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opiates4.638.431.513.66.23.11.7122.5233907049
Cocaine6.841.426.312.86.73.51.70.822.2235946559
Stimulants12.864.415.14.61.70.80.40.118.854341421
Hypnotics and sedatives9.522.418.211.711.89.37.11028.11203429
Hallucinogens16.361.817.13.60.40.700.118.3719214
Volatile substances52.137.45.52.500.60.61.216.616346
Cannabis 32.456.67.520.80.40.20.217.1223916360
Other substances 24.547.410.76.731.35.11.320.2625594
Total14.346.421.39.24.52.41.30.820.67751922672

Notes:

 Countries reporting data: BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LV, MT, NL, AT, SK, FI, SE. 

 Last data available from Spain refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-106 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008